The association between non-alcoholic fatty liver disease and valvular heart disease.


Journal

Minerva cardioangiologica
ISSN: 1827-1618
Titre abrégé: Minerva Cardioangiol
Pays: Italy
ID NLM: 0400725

Informations de publication

Date de publication:
Feb 2020
Historique:
pubmed: 4 12 2019
medline: 15 12 2020
entrez: 3 12 2019
Statut: ppublish

Résumé

Non-alcoholic fatty liver (NAFLD) disease has become the commonest cause of end-stage liver disease. Patients with NAFLD have an increased risk of associated extrahepatic conditions, including structural and functional cardiovascular disease. Still, it is unknown if there is an association between NAFLD and valvular heart disease (VHD). The aim of this paper was to determine the association between NAFLD and VHD. We performed a single center retrospective study in EMMS Nazareth Hospital from April 2010 to April 2018. All patients who were diagnosed with NAFLD and who had an echocardiography performed within one year were included. Subjects age and sex-matched, who had echocardiography performed in the same period were included in the control group. The mean age of the NAFLD group was 41.5±11.7 vs. 42.8±10.8 years of the control group (P=0.2). The prevalence of aortic stenosis, aortic insufficiency, mitral stenosis and mitral insufficiency were significantly higher in NAFLD patients compared to the control group (1.2% vs. 0.22%, 1.32% vs. 0.32%, 0.66% vs. 0.27%, and 1.87% vs. 0.41%, respectively; P<0.001). In the multivariate logistic regression analysis, NAFLD was found to be independent risk factor for VHD (OR 2.39, 95% CI 2.17-2.78, P<0.001). VHD was significantly seen more frequently in NAFLD patients compared to controls. Prospective studies are needed to validate our findings and to elucidate the pathogenesis of VHD in patients with NAFLD.

Sections du résumé

BACKGROUND BACKGROUND
Non-alcoholic fatty liver (NAFLD) disease has become the commonest cause of end-stage liver disease. Patients with NAFLD have an increased risk of associated extrahepatic conditions, including structural and functional cardiovascular disease. Still, it is unknown if there is an association between NAFLD and valvular heart disease (VHD). The aim of this paper was to determine the association between NAFLD and VHD.
METHODS METHODS
We performed a single center retrospective study in EMMS Nazareth Hospital from April 2010 to April 2018. All patients who were diagnosed with NAFLD and who had an echocardiography performed within one year were included. Subjects age and sex-matched, who had echocardiography performed in the same period were included in the control group.
RESULTS RESULTS
The mean age of the NAFLD group was 41.5±11.7 vs. 42.8±10.8 years of the control group (P=0.2). The prevalence of aortic stenosis, aortic insufficiency, mitral stenosis and mitral insufficiency were significantly higher in NAFLD patients compared to the control group (1.2% vs. 0.22%, 1.32% vs. 0.32%, 0.66% vs. 0.27%, and 1.87% vs. 0.41%, respectively; P<0.001). In the multivariate logistic regression analysis, NAFLD was found to be independent risk factor for VHD (OR 2.39, 95% CI 2.17-2.78, P<0.001).
CONCLUSIONS CONCLUSIONS
VHD was significantly seen more frequently in NAFLD patients compared to controls. Prospective studies are needed to validate our findings and to elucidate the pathogenesis of VHD in patients with NAFLD.

Identifiants

pubmed: 31789009
pii: S0026-4725.19.05087-4
doi: 10.23736/S0026-4725.19.05087-4
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

42-46

Commentaires et corrections

Type : CommentIn

Auteurs

Amir Mari (A)

Unit of Gastroenterology and Endoscopy, The Nazareth Hospital, EMMS, Nazareth, Israel - amir.mari@hotmail.com.
Faculty of Medicine, Bar-Ilan University, Safed, Israel - amir.mari@hotmail.com.

Tawfik Khoury (T)

Unit of Gastroenterology and Endoscopy, The Nazareth Hospital, EMMS, Nazareth, Israel.
Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Department of Gastroenterology, Galilee Medical Center, Nahariya, Israel.

Helal Said Ahmad (H)

Unit of Gastroenterology and Endoscopy, The Nazareth Hospital, EMMS, Nazareth, Israel.
Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Department of Gastroenterology, Galilee Medical Center, Nahariya, Israel.

Fadi Abu Baker (F)

Department of Gastroenterology and Hepatology, Hillel Yaffe Medical Center, Hadera, Israel.
Technion Faculty of Medicine, Haifa, Israel.

Anas Kadah (A)

Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Department of Gastroenterology, Galilee Medical Center, Nahariya, Israel.

Wisam Sbeit (W)

Faculty of Medicine, Bar-Ilan University, Safed, Israel.
Department of Gastroenterology, Galilee Medical Center, Nahariya, Israel.

Rinaldo Pellicano (R)

Unit of Gastroenterology, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Mahmud Mahamid (M)

Unit of Gastroenterology and Endoscopy, The Nazareth Hospital, EMMS, Nazareth, Israel.
Faculty of Medicine, Bar-Ilan University, Safed, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH